MCC protocol: Clinical Trials

3 trials of MCC protocol, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed. 3 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 43Completed 3

Follow MCC protocol: new trials by email Literature Review of MCC protocol trials Research Report on MCC protocol

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Effects of Carboxymethylcellulose Artificial Tears on the Eye Microbiome
Carboxymethylcellulose (CMC) Artificial Tears, Preservative-free, CMC-free Artificial Tears (control) - Dry Eye Syndromes
Phase 4CompletedUniversity of Florida802022-04-222023-04-20
Evaluating HA 0.15% Compared With Cyclosporine 0.05%, and Efficacy of Combination Therapy in Dry Eye Disease Patients
TJO-018 (HA 0.15%), Cyclosporine Ophthalmic Emulsion 0.05% standard therapy (CMC 0.5% add), TJO-018 (HA 0.15%) + Cyclosporine Ophthalmic Emulsion 0.05% - Dry Eye, Dry Eye Syndromes
Phase 4CompletedTaejoon Pharmaceutical Co., Ltd.4382019-11-122022-06-08
Comparative Study of 0.5% Carboxymethylcellulose With 0.005% Stabilized Oxychlorocomplex (PURITEā„¢) Versus 0.5% Carboxymethylcellulose in the Treatment of Dry Eye
0.5% carboxymethylcellulose (CMC) with purite and CMC alone - Dry Eye Syndromes
Phase 4CompletedChulalongkorn University1002004-02-012015-06-03

Conditions studied

Dry Eye Syndromes (3)

Sponsors

Chulalongkorn University (1)  ·  Taejoon Pharmaceutical Co., Ltd. (1)  ·  University of Florida (1)

Countries

South Korea (1)  ·  Thailand (1)  ·  United States (1)

Top investigators

Nipaporn Maneerat, MD (1)  ·  Pitipong Suramethakul, MD (1)  ·  Vilavun Puangsricharern, MD (1)  ·  Yujia Zhou (1)

Results publications

PMID 37555738